Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Virtual reality-based neuroproprioceptive physiotherapy in multiple sclerosis: a protocol for a double-arm randomised assessor-blinded controlled trial on upper extremity function, postural function and quality of life, with molecular and functional MRI assessment

B. Miznerova, J. Reissigova, L. Vasa, J. Frank, M. Hudec, L. Rodina, A. Herynkova, J. Havlik, J. Tintera, J. Rydlo, I. Ibrahim, VB. O'Leary, M. Cerna, I. Jurickova, M. Pokorna, T. Philipp, J. Hlinovska, I. Stetkarova, K. Rasova

. 2025 ; 15 (1) : e088046. [pub] 20250109

Language English Country England, Great Britain

Document type Journal Article, Clinical Trial Protocol

INTRODUCTION: Upper limb (UL) impairment is common in people with multiple sclerosis (pwMS), and functional recovery of the UL is a key rehabilitation goal. Technology-based approaches, like virtual reality (VR), are increasingly promising. While most VR environments are task-oriented, our clinical approach integrates neuroproprioceptive 'facilitation and inhibition' (NFI) principles. To advance this, we developed immersive VR software based on NFI principles targeting UL function and sit-to-stand ability. This study aims to evaluate the effectiveness of this VR therapy compared with conventional NFI-based physical therapy in pwMS. Our study uniquely applies advanced imaging techniques, along with biological molecular assessments, to explore adaptive processes induced by VR rehabilitation. METHODS AND ANALYSIS: This double-arm, randomised, assessor-blinded, controlled trial runs over 2 months (1 hour, 2 times per week). PwMS with mild to severe disability will receive either VR therapy or real-world physical therapy. Primary outcomes include the nine-hole peg test, box and block test, handgrip strength, tremor and five times sit-to-stand test. Secondary measures include the Multiple Sclerosis Impact Scale, the 5-level EQ-5D questionnaire and kinematic analysis. Adaptive processes will be monitored using imaging techniques (functional MRI and tractography), molecular genetic methods (long non-coding RNAs) and immune system markers (leukocytes, dendritic cells). The International Classification of Functioning, Disability and Health brief set for MS will map the bio-psycho-social context of participants. ETHICS AND DISSEMINATION: This project and its amendments were approved by the Ethics Committee of the Institute for Clinical and Experimental Medicine and Thomayer Hospital (1983/21+4772/21 (G-21-02) and the Ethics Committee of Kralovske Vinohrady University Hospital (EK-VP/38/0/2021) in Prague, Czechia (with single enrolment). The findings of this project will be disseminated through scientific publications, conferences, professional networks, public engagement, educational materials and stakeholder briefings to ensure a broad impact across clinical, academic and public domains. TRIAL REGISTRATION NUMBER: clinicaltrials.gov (NCT04807738).

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010297
003      
CZ-PrNML
005      
20250429135339.0
007      
ta
008      
250415s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/bmjopen-2024-088046 $2 doi
035    __
$a (PubMed)39788766
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Miznerova, Barbora $u Department of Rehabilitation and Sports Medicine, Second Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic $u Department of Rheumatology and Physiotherapy, Third Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000316170656
245    10
$a Virtual reality-based neuroproprioceptive physiotherapy in multiple sclerosis: a protocol for a double-arm randomised assessor-blinded controlled trial on upper extremity function, postural function and quality of life, with molecular and functional MRI assessment / $c B. Miznerova, J. Reissigova, L. Vasa, J. Frank, M. Hudec, L. Rodina, A. Herynkova, J. Havlik, J. Tintera, J. Rydlo, I. Ibrahim, VB. O'Leary, M. Cerna, I. Jurickova, M. Pokorna, T. Philipp, J. Hlinovska, I. Stetkarova, K. Rasova
520    9_
$a INTRODUCTION: Upper limb (UL) impairment is common in people with multiple sclerosis (pwMS), and functional recovery of the UL is a key rehabilitation goal. Technology-based approaches, like virtual reality (VR), are increasingly promising. While most VR environments are task-oriented, our clinical approach integrates neuroproprioceptive 'facilitation and inhibition' (NFI) principles. To advance this, we developed immersive VR software based on NFI principles targeting UL function and sit-to-stand ability. This study aims to evaluate the effectiveness of this VR therapy compared with conventional NFI-based physical therapy in pwMS. Our study uniquely applies advanced imaging techniques, along with biological molecular assessments, to explore adaptive processes induced by VR rehabilitation. METHODS AND ANALYSIS: This double-arm, randomised, assessor-blinded, controlled trial runs over 2 months (1 hour, 2 times per week). PwMS with mild to severe disability will receive either VR therapy or real-world physical therapy. Primary outcomes include the nine-hole peg test, box and block test, handgrip strength, tremor and five times sit-to-stand test. Secondary measures include the Multiple Sclerosis Impact Scale, the 5-level EQ-5D questionnaire and kinematic analysis. Adaptive processes will be monitored using imaging techniques (functional MRI and tractography), molecular genetic methods (long non-coding RNAs) and immune system markers (leukocytes, dendritic cells). The International Classification of Functioning, Disability and Health brief set for MS will map the bio-psycho-social context of participants. ETHICS AND DISSEMINATION: This project and its amendments were approved by the Ethics Committee of the Institute for Clinical and Experimental Medicine and Thomayer Hospital (1983/21+4772/21 (G-21-02) and the Ethics Committee of Kralovske Vinohrady University Hospital (EK-VP/38/0/2021) in Prague, Czechia (with single enrolment). The findings of this project will be disseminated through scientific publications, conferences, professional networks, public engagement, educational materials and stakeholder briefings to ensure a broad impact across clinical, academic and public domains. TRIAL REGISTRATION NUMBER: clinicaltrials.gov (NCT04807738).
650    _2
$a lidé $7 D006801
650    12
$a horní končetina $x patofyziologie $7 D034941
650    12
$a roztroušená skleróza $x diagnostické zobrazování $7 D009103
650    12
$a magnetická rezonanční tomografie $x metody $7 D008279
650    12
$a kvalita života $7 D011788
650    12
$a techniky fyzikální terapie $7 D026741
650    _2
$a virtuální realita $7 D000076142
650    _2
$a randomizované kontrolované studie jako téma $7 D016032
650    _2
$a dvojitá slepá metoda $7 D004311
650    _2
$a terapie pomocí virtuální reality $x metody $7 D063367
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a postura těla $7 D011187
650    _2
$a síla ruky $7 D018737
655    _2
$a časopisecké články $7 D016428
655    _2
$a protokol klinické studie $7 D000078325
700    1_
$a Reissigova, Jindra $u Institute of Computer Science, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Vasa, Libor $u Department of Computer Science and Engineering, Faculty of Applied Sciences, University of West Bohemia, Plzen, Czech Republic
700    1_
$a Frank, Jakub $u Department of Computer Science and Engineering, Faculty of Applied Sciences, University of West Bohemia, Plzen, Czech Republic
700    1_
$a Hudec, Michael $u Department of Medical Genetics, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Rodina, Lubomir $u Department of Rehabilitation Medicine, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic $u Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic
700    1_
$a Herynkova, Anna $u Department of Rheumatology and Physiotherapy, Third Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
700    1_
$a Havlik, Jan $u Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic
700    1_
$a Tintera, Jaroslav $u Institute of Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Rydlo, Jan $u Institute of Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Ibrahim, Ibrahim $u Institute of Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a O'Leary, Valerie B $u Department of Medical Genetics, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Cerna, Marie $u Department of Medical Genetics, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Jurickova, Iva $u Department of Medical Genetics, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Pokorna, Marketa $u Department of Medical Genetics, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Philipp, Tom $u Department of Rheumatology and Physiotherapy, Third Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
700    1_
$a Hlinovska, Jana $u Department of Rheumatology and Physiotherapy, Third Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
700    1_
$a Stetkarova, Ivana $u Department of Neurology, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic
700    1_
$a Rasova, Kamila $u Department of Rheumatology and Physiotherapy, Third Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic kamila.rasova@lf3.cuni.cz $u Department of Rehabilitation Medicine, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic $1 https://orcid.org/0000000232011770 $7 mzk2007417576
773    0_
$w MED00184484 $t BMJ open $x 2044-6055 $g Roč. 15, č. 1 (2025), s. e088046
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39788766 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135335 $b ABA008
999    __
$a ok $b bmc $g 2311574 $s 1247378
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 15 $c 1 $d e088046 $e 20250109 $i 2044-6055 $m BMJ open $n BMJ Open $x MED00184484
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...